CLuB in the Press

Professor Lorraine O’Driscoll discusses advancements in cancer treatments and why COVID-19 serves as a reminder that fundamental research is just as important as applied research in an interview with Silicon Republic.

Previous
Previous

Professor Lorraine O’Driscoll to lead the €4 million All-Ireland Cancer Liquid Biopsies Consortium (CLuB) Emerging Hub of Excellence.